News related to Afinitor (Everolimus) and/or conditions it is approved for
Mixed Results With Afinitor in Advanced Breast Cancer (CME/CE)
Source: MedPage Today Oncology/Hematology [2014.12.15]
(MedPage Today) -- Results in women with HER2-positive disease fall short, but a subset of patients see some survival benefit.
FDA OKs New Kids' Dose of Cancer Drug
Source: MedPage Today Product Alert [2012.08.30]
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.